Longevity & Anti-Aging Technology
Calico Life Sciences Platform
by Calico Life Sciences LLC
Alphabet-backed research lab harnessing biology to understand the biology of aging
Category
Longevity & Anti-Aging Technology
Founded
2013
Headquarters
South San Francisco, CA, USA
Overview
Calico Life Sciences is a research and development company established by Google (Alphabet) with the mission of understanding the biology of aging and developing interventions that extend healthy human lifespan. Calico operates as a discovery engine pursuing basic research into the molecular, cellular, and organismal mechanisms of aging, including studies in long-lived animal models, genetics of longevity in human populations, and the role of specific pathways such as mTOR, NAD+, and epigenetic regulation in aging. Calico has forged a major research and development collaboration with AbbVie valued at up to $1.5 billion, providing resources to advance discoveries from the lab through clinical development. The partnership has generated multiple clinical-stage programs and resulted in publication of research on the genetics and biology of aging across diverse model organisms including the naked mole-rat, a remarkably long-lived rodent. Calico distinguishes itself through its long time horizon and resource depth, enabling it to pursue fundamental questions in aging biology that shorter-funded organizations cannot. The company employs world-class computational biologists, geneticists, and bioinformaticians alongside wet-lab scientists, enabling an integrated approach where large-scale data generation and machine learning inform experimental design at the frontier of longevity science.
Key Features
Aging Pathway Modeling
Computational models of aging pathways including mTOR, AMPK, sirtuins, and cellular senescence.
Clinical Trial Design
Novel endpoint designs and biomarker strategies for longevity intervention clinical trials.
Proteomics Age Prediction
Plasma proteomics-based age prediction and organ-specific aging assessment.
Metabolomic Aging Signatures
Identify metabolomic patterns predictive of healthspan and response to longevity interventions.
Epigenetic Profiling
Comprehensive epigenetic analysis revealing methylation patterns associated with biological age.
Pros & Cons
Pros
- +Cellular reprogramming technologies reverse age-related epigenetic changes in human cells
- +AI-driven target identification discovers novel longevity pathways from large-scale aging datasets
- +Multi-omics aging clocks quantify biological age with higher accuracy than chronological measures
- +Clinical trial infrastructure supports novel endpoint designs for longevity interventions
- +Integration of proteomics, metabolomics, and epigenomics provides comprehensive aging profiles
- +Longitudinal biomarker tracking monitors intervention effectiveness over extended time periods
- +Senolytic drug discovery platforms identify compounds that selectively eliminate senescent cells
Cons
- −Ethical debates around life extension technologies create public perception and policy challenges
- −Biomarker surrogates for aging may not accurately predict actual healthspan extension
- −Regulatory pathways for aging interventions are unclear as aging is not classified as a disease
- −Long study durations required to demonstrate meaningful lifespan extension create business model challenges
Use Cases
Research Workflow Optimization
AI-powered optimization of research workflows to accelerate discovery timelines and improve reproducibility.
Data Analysis & Insights
Machine learning analysis of complex biological datasets to extract actionable insights and identify patterns.
Collaboration & Knowledge Management
Platform-enabled collaboration across distributed research teams with integrated data sharing and knowledge capture.